NDC 73309-042 - Isoproterenol HCl
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73309-042
- Package NDCs from labels
- 73309-042-01
- Manufacturer
- Bluebay Shandong Co, LTD. | Shenzhen Oriental Pharmaceutical Co. Ltd
- Effective date
- 2019-10-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Isoproterenol HCl - Bluebay Shandong Co, LTD. | Shenzhen Oriental Pharmaceutical Co. Ltd | Bluebay Shandong Co, LTD. | Shenzhen Oriental Pharmaceutical Co. Ltd | 2019-10-16 | BULK INGREDIENT |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73309-042-01 | Isoproterenol HCl | 50 g in 1 JAR | POWDER | 50 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Isoproterenol hydrochloride | ISOPROTERENOL HYDROCHLORIDE | KVK-Tech, Inc. | 051acbc2-7bf8-4059-e063-6394a90a115b | 2026-03-17 | Warnings, Adverse reactions | DIA2A74855 |
| Isoproterenol Hydrochloride | ISOPROTERENOL HYDROCHLORIDE | Eugia US LLC | 3e4050e8-7d94-4ed7-951d-1ff818ddadf1 | 2025-12-16 | Warnings, Adverse reactions | DIA2A74855 |
| Isoproterenol Hydrochloride | ISOPROTERENOL HYDROCHLORIDE | Nexus Pharmaceuticals LLC | dfb97590-dcbf-47e7-bbfe-f01580eb6ed0 | 2025-09-16 | Warnings, Adverse reactions | DIA2A74855 |
| Isoproterenol Hydrochloride | ISOPROTERENOL HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | d140b27a-3bf7-4e0f-bb91-02b588184f52 | 2025-06-23 | Warnings, Adverse reactions | DIA2A74855 |
| Isoproterenol Hydrochloride | ISOPROTERENOL HYDROCHLORIDE | Sagent Pharmaceuticals | d2a9b767-0274-49bf-83cd-2fcce9bedc78 | 2025-01-06 | Warnings, Adverse reactions | DIA2A74855 |
| isoproterenol hydrochloride | ISOPROTERENOL HYDROCHLORIDE | Gland Pharma Limited | 2581854e-e654-4ac3-98e8-36c9f27748bf | 2024-10-07 | Warnings, Adverse reactions | DIA2A74855 |
| Isoproterenol Hydrochloride | ISOPROTERENOL HYDROCHLORIDE | Nordic Pharma, Inc. | 046f2941-3bc0-4755-861c-71bedb49e706 | 2024-06-27 | Warnings, Adverse reactions | DIA2A74855 |
| Isoproterenol Hydrochloride | ISOPROTERENOL HYDROCHLORIDE | Nordic Pharma, Inc. | 124f44db-b6ba-4886-bfc7-8c71e60ac5b4 | 2024-06-20 | Warnings, Adverse reactions | DIA2A74855 |
| Isoproterenol Hydrochloride | ISOPROTERENOL HYDROCHLORIDE | Avenacy, Inc. | 212af0f4-42c7-425d-8baf-9a2f594289a2 | 2024-05-15 | Warnings, Adverse reactions | DIA2A74855 |
| ISOPROTERENOL | ISOPROTERENOL HYDROCHLORIDE | Cipla USA Inc. | f724120d-da28-4065-9e05-d7dd6afbb546 | 2024-01-14 | Warnings, Adverse reactions | DIA2A74855 |
| Isoproterenol Hydrochloride | ISOPROTERENOL HYDROCHLORIDE | Armas Pharmaceuticals Inc. | 56cb205c-8329-454a-a6be-e05e497de81e | 2023-07-27 | Warnings, Adverse reactions | DIA2A74855 |
| Isoproterenol Hydrochloride | ISOPROTERENOL HYDROCHLORIDE | Amneal Pharmaceuticals LLC | f80ce132-1570-43bf-b4a6-0ffbdea5d218 | 2023-02-22 | Warnings, Adverse reactions | DIA2A74855 |
| Isoproterenol Hydrochloride | ISOPROTERENOL HYDROCHLORIDE | Micro Labs Limited | 0f6a7651-e7b4-4ada-8ccd-2123d094a113 | 2022-11-14 | Warnings, Adverse reactions | DIA2A74855 |
| ISOPROTERENOL HYDROCHLORIDE | ISOPROTERENOL HYDROCHLORIDE | Amphastar Pharmaceuticals, Inc. | 86b2455a-0489-405e-bd0b-9f79d3c5350d | 2022-10-01 | Warnings, Adverse reactions | DIA2A74855 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.